Organovo Holdings Inc.
Company Snapshot
Founded: 2007
Entity Type: Public
Employees: 20
Region: U.S.
Revenue: $0.1 Millions
Revenue Year: 2023
Headquarter: U.S.
Key Geographics: U.S.
Corporate Address: 11555 Sorrento Valley Road, Suite 100 San Diego, California 92121 U.S. Tel: +1-(858)-224-1000 Web: www.organovo.com
Company Overview
Organovo is a clinical-stage biotechnology company dedicated to developing drugs proven effective in three-dimensional (3D) human tissues as potential candidates for drug development. The company utilizes proprietary technology to construct 3D human tissues replicating essential aspects of native human tissue composition, architecture, function, and disease characteristics.
Financial Highlights (FY 2023)
Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***
This information is available for BCC Research members only.
Organovo Holdings Inc. In News
Company's Business Segments
- Research & Development : This segment includes the company's drug development efforts.
- Mosaic Cell Sciences : This segment serves as a key source of certain primary human cells, which are utilized in research and development efforts.
Applications/End User Industries
- Biotechnology
- Pharmaceuticals